Managing these risks, as well as looking at novel approaches to help lower the chances of another stroke, heart attack or death among this population are all critical steps in increasing stroke survival and improving the quality of life for people who have had a stroke. In this study, Sheffeh and colleagues evaluated whether two classes of medications for treating Type 2 diabetes are associated with a decreased risk of heart attacks, secondary stroke or death in stroke survivors
EpitalON is not approved as a medicine in the UK or EU
Want more guidance on gentle eating during your GLP-1 journey
Long-circulating and target-specific nanoparticles: theory to practice
Choose formulas free from fillers and artificial additives, enriched with whole foods to provide additional nutrients and antioxidants to help support cellular health
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027